Our pioneering work in AI-guided mRNA immunotherapy is reshaping companion animal care, meeting the escalating demand for premium vaccines and therapies. Adiverna is poised for rapid growth and substantial impact in the veterinary industry.
Adiverna was founded in stealth mode with a clear vision to enhance pet health using mRNA-based vaccines. Since inception, our expertise in mRNA immunotherapy has positioned us as leaders in personalized animal healthcare.
Over the years, Adiverna’s dedication to innovation and commitment to advancing veterinary medicine have garnered significant recognition and trust within the industry.